Related Experiment Video
Updated: Jun 4, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
HLA-DRBeta1, circulating Th1/Th2 cytokines and immunological homunculus in coronary atherosclerosis
Amrollah Mostafazadeh1, Mehrdad Saravi, Haleh Akhavan Niaki
1Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran. amrolah65@yahoo.com
Insights
This study suggests that the anti-inflammatory cytokine Interleukin-10 (IL-10) and the HLA-DR16 allele may protect against coronary atherosclerosis by potentially counteracting LDL-cholesterol effects.
Area of Science:
- Immunogenetics
- Cardiovascular Research
- Molecular Biology
Background:
- Coronary atherosclerotic disease (CAD) is a leading global health concern.
- The role of human leukocyte antigen (HLA) alleles and cytokine profiles in CAD pathogenesis requires further investigation.
Purpose of the Study:
- To explore the association between Human Leukocyte Antigen (HLA)-DRB1 alleles and circulating Th1/Th2 cytokine levels in patients with coronary atherosclerosis.
- To investigate the relationship between lipid profiles and these immunological markers in different CAD patient groups.
Main Methods:
- Serum samples from 31 unstable angina, 27 chronic stable angina patients, and 24 controls were analyzed for Th1/Th2 cytokines (IL-10, IFN-gamma, IL-4) using ELISA.
- HLA-DRB1 alleles were typed in 24 subjects using SSP-PCR.
- Lipid profiles were determined using standard clinical laboratory methods.
Main Results:
- Normal controls exhibited significantly higher mean serum IL-10 levels compared to unstable angina (p<0.028) and chronic stable angina groups.
- No significant differences were observed in serum levels of IFN-gamma and IL-4 among the groups.
- HLA-DR16 was present in 33.33% of normal controls but absent in all CAD patients.
Conclusions:
- Elevated IL-10 and the presence of HLA-DR16 in normal controls suggest a potential protective role against coronary atherosclerosis.
- This may involve dampening the atherogenic effects of LDL-cholesterol, possibly mediated by HDL-cholesterol and anti-inflammatory pathways.
Abstract:
Coronary atherosclerotic disease is one of the most endangering health disorder worldwide. This study was designed to investigate the correlation between HLA-DR1 alleles and circulating Th1/Th2 type cytokines in coronary atherosclerosis. By Elisa, Th1/Th2 type cytokines were determined in serum samples of 31 subjects with unstable angina, 27 subjects with chronic stable angina and 24 individuals as normal control. By SSP-PCR, more than 100 alleles of HLA-DRBeta1 were typed in 24 subjects who had skewed serum levels of Th1/Th2 type cytokines. Lipid profiles were determined by the routine methods of clinical laboratory in all subjects. The mean serum concentration of IL-10 in normal control subjects was higher in comparison to the patient groups.0.33±0.59 pg/ml versus 0.064±0.3 pg/ml in unstable angina pectoris group (p<0.028) and 0.22±0.6 pg/ml in chronic stable subjects. There was no statistically significant difference among the groups in serum levels of other desired cytokines (IFN-Gamma, IL-4). 33.33% of normal control subjects were HLA-DR16 positive whereas none of the subjects with chronic stable angina or individuals with unstable angina pectoris was positive for this antigen. The mean concentration of serum LDL-cholesterol in normal control group was high 142.046±35.40 (pg/ml).This preliminary study shows that the atherogenic effect of the LDL- cholesterol may be dampened by HDL-cholesterol through anti inflammatory cytokine IL-10 and HLA-DR16, a phenomenon interpretable via immunological homunculus theory.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
